BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
24.73
-0.59 (-2.33%)
At close: Aug 15, 2025, 12:10 PM

BioLife Solutions Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
76.51M 79.42M 73.91M 110.06M 103.07M 114.25M 133.52M 145.04M 162.22M 163.24M 161.76M 154.8M 147.86M 138.53M 119.16M 96.58M 74.06M 52.77M
Cost of Revenue
13.26M 18.66M 30.59M 66.68M 79.59M 93.85M 97.44M 103.33M 108.66M 107.15M 107.94M 108.09M 105.94M 98.3M 81.41M 57.72M 37.68M 23.63M
Gross Profit
63.25M 60.76M 56.62M 56.68M 46.87M 43.79M 46.18M 51.82M 53.56M 56.09M 53.82M 46.72M 41.91M 40.22M 37.75M 38.86M 36.37M 29.14M
Operating Income
-17.23M -4.19M -6.26M -15.1M -22.29M -34.77M -44.36M -47.12M -47.43M -40.87M -38.94M -46.92M -49.02M -44.85M -34.88M -21.43M -11.52M -6.92M
Interest Income
681K 681K n/a n/a n/a n/a n/a 506K 506K 506K 506K n/a n/a n/a n/a n/a 16K 34K
Pretax Income
-16.33M -7.77M -10.52M -19.31M -33.27M -36.31M -46.75M -88.78M -83.65M -149.75M -143.79M -112.5M -106.85M -35.24M -28.69M -16.1M -12.32M -24.02M
Net Income
-5.53M -10.41M -20.18M -46.03M -73.45M -62.94M -66.43M -102.23M -83.06M -145.41M -138.77M -104.8M -94.76M -14.33M -8.38M 4.71M 3.5M -20.76M
Selling & General & Admin
48.92M 49.19M 53.09M 64.8M 65.6M 72.92M 76.23M 77.28M 78.45M 73.5M 68.27M 66.52M 63.8M 57.33M 48.09M 37.85M 28.8M 23.15M
Research & Development
8.06M 7.72M 9.05M 12.37M 15.72M 18.18M 18.79M 18.56M 16.58M 15.17M 14.8M 14.2M 14M 13.61M 11.82M 10.11M 8.61M 7.04M
Other Expenses
24.31M 8.04M 7.33M 7.33M 7.29M 6.77M 8.23M 9.69M 5.82M 8.29M 9.7M 8.54M 6.02M 3.03M 155K -145K -130K 9K
Operating Expenses
81.28M 64.94M 69.48M 84.5M 88.6M 98.92M 104.31M 106.59M 101.91M 96.96M 92.77M 91.82M 88.92M 81.07M 68.11M 54.23M 41.86M 33.47M
Interest Expense
835K 512K 719K 1.34M 1.55M 1.58M 1.78M 1.71M 1.25M 896K 669K 332K 511K 600K 432K 331K 140K 19K
Selling & Marketing Expenses
8.08M 8.85M 8.63M 13.96M 15.29M 18.11M 22.2M 23.65M 24.05M 23.15M 21.57M 20.35M 19.14M 16.86M 13.99M 11.11M 8.63M 6.86M
Cost & Expenses
94.54M 83.6M 80.17M 131.28M 138.2M 162.78M 191.64M 199.81M 210.57M 204.11M 200.7M 199.91M 194.86M 179.38M 149.52M 111.95M 79.55M 57.1M
Income Tax Expense
-19K -144K -141K -53K 90K 94K 169K 126K -588K -4.33M -5.02M -7.7M -12.09M -20.91M -20.31M -20.8M -15.82M -3.26M
Shares Outstanding (Basic)
47.8M 47.13M 46.65M 46.18M 46M 45.43M 44.82M 43.57M 43.44M 43.03M 42.79M 42.65M 42.46M 42.01M 41.68M 40.91M 38.07M 33.24M
Shares Outstanding (Diluted)
47.8M 47.13M 48.03M 46.18M 46M 45.43M 44.82M 43.57M 43.44M 43.03M 42.79M 42.65M 42.46M 42.01M 41.68M 43.3M 40.39M 33.24M
EPS (Basic)
-0.11 -0.23 -0.44 -1.01 -1.64 -1.42 -1.52 -2.37 -1.93 -3.42 -3.28 -2.5 -2.27 -0.35 -0.2 0.10 0.07 -0.83
EPS (Diluted)
-0.12 -0.24 -0.45 -1.01 -1.64 -1.42 -1.52 -2.37 -1.93 -3.42 -3.28 -2.5 -2.27 -0.36 -0.21 0.09 0.05 -0.84
EBITDA
-8.07M 9.3M 1.53M -15.75M -41.4M -49.65M -51.66M -47.89M -29.62M -93.94M -87.12M -92.56M -93.32M -23.2M -19.17M -15.96M -8.55M -7.59M
EBIT
-13.35M 1.54M -288K -18.25M -45.33M -49.63M -59.8M -58.06M -40.42M -111.58M -106.2M -110.46M -110.51M -38.78M -32.05M -24.74M -14.86M -11.71M
Depreciation & Amortization
6.79M 7.77M 8.66M 9.34M 10.77M 11.47M 12.79M 16.11M 16.4M 18.59M 20.03M 19.07M 19.45M 17.84M 14.92M 11.1M 7.4M 4.46M